Korormicin, an antibiotic specific for gram-negative marine bacteria, strongly inhibits the respiratory chain-linked Na+-translocating NADH: quinone reductase from the marine Vibrio alginolyticus.
Yoshikawa
K
K
Marine Biotechnology Institute, Shimizu Laboratories, Japan.
Nakayama
Y
Y
Hayashi
M
M
Unemoto
T
T
Mochida
K
K
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins; D003470:Culture Media; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D007700:Kinetics; D007783:Lactones / Q000494:pharmacology; D009245:NADH Dehydrogenase / Q000378:metabolism; D011808:Quinone Reductases / Q000037:antagonists & inhibitors*; D014733:Vibrio / Q000187:drug effects / Q000201:enzymology*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D003470:Culture Media; D004791:Enzyme Inhibitors; D005231:Fatty Acids, Unsaturated; D007783:Lactones; C111296:korormicin; C084142:sodium-translocating NADH-quinone reductase; D011808:Quinone Reductases; D009245:NADH Dehydrogenase